TABLE 1.
Summary of baseline demographics
| Placebo- oxytocin, N = 12 |
Oxytocin- placebo, N =12 |
Overall, N = 24 |
|
|---|---|---|---|
| Gender | |||
| Male | 4 | 8 | 9 (38%) |
| Female | 5 | 7 | 15 (62%) |
| Ethnicity | |||
| Hispanic | 0 | 1 | 1 (4%) |
| Non-Hispanic | 12 | 11 | 23 (96%) |
| Race | |||
| Asian | 0 | 1 | 1 (4%) |
| African–American | 0 | 1 | 1 (4%) |
| Caucasian | 12 | 10 | 22 (92%) |
| Nutritional phase | |||
| 2a | 0 | 1 | 1 (4%) |
| 2b | 8 | 6 | 14 (58%) |
| 3 | 4 | 5 | 9 (38%) |
| Age | |||
| Mean | 8.4 | 8.1 | 8.2 |
| SD | 2.1 | 1.4 | 1.7 |
| Min | 5.9 | 5.5 | 5.5 |
| Max | 11.8 | 10.2 | 11.8 |
| PWS type | |||
| Deletion | 8 | 10 | 18 |
| Uniparental disomy | 4 | 1 | 5 |
| Imprinting defect | 0 | 1 | 1 |